Elan Corporation has completed its previously announced acquisition of The Liposome Company, following approval by the shareholders of Liposome last Friday, the company said at the weekend. The deal is a strategic step for Elan into the oncology market and will see Liposome operate as a separate business unit within Elan.
Liposome purchase completed by Elan
Elan Corporation has completed its previously announced acquisition of The Liposome Company, following approval by the shareholders…
Join The Irish Times on WhatsApp and stay up to date
Sign up to the Business Today newsletter for the latest new and commentary in your inbox
Listen to Inside Business podcast for a look at business and economics from an Irish perspective







